Literature DB >> 15476518

Intravenous urography-virtual cystoscopy is a better preliminary examination than air virtual cystoscopy.

Noriyasu Kawai1, Takeo Mimura, Daisuke Nagata, Keiichi Tozawa, Kenjiro Kohri.   

Abstract

OBJECTIVE: To describe a new technique of virtual cystoscopy (VC, used previously but with catheterization to drain residual urine and insufflation with air or carbon dioxide) with no invasive catheterization, used in parallel with intravenous urography (IVU), as conventional cystoscopy is an invasive but essential examination, and VC with multislice computed tomography (CT) was introduced to make preliminary examinations noninvasive. PATIENTS AND METHODS: Using multislice CT and a device with 16 rows of detectors, we examined five patients using VC that previously involved catheterization, termed 'air VC' and 16 using VC with the new technique, termed 'IVU VC'. We assessed the new technique by evaluating the tumour detection rate, and merits and demerits of both types of VC.
RESULTS: The detection rate of bladder tumours by IVU VC was similar to that from air VC; moreover, IVU VC overcame two significant disadvantages of air VC, i.e. the appearance of the water surface and the need for catheterization.
CONCLUSION: Conventional cystoscopy is still an essential examination but this new method of IVU VC may be ideal for preliminary examination of the bladder.

Entities:  

Mesh:

Year:  2004        PMID: 15476518     DOI: 10.1111/j.1464-410X.2004.05042.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  2 in total

Review 1.  New imaging modalities in bladder cancer.

Authors:  Mansi A Saksena; Douglas M Dahl; Mukesh G Harisinghani
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  64-detector row CT cystography with virtual cystoscopy in the detection of bladder carcinoma: preliminary experience in selected patients.

Authors:  V Panebianco; M Osimani; D Lisi; E Santucci; M Ciccariello; S Iori; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.